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 Re: Enhancing Cancer 
Registry Data to Promote 
Rational Health System 
Design
 In her recent editorial in the Journal, Schrag 
( 1 ) underlined the importance of including 
comorbidity and performance status when 
comparing survival outcomes between gener-
alized and specialized centers. The character-
istics of patients who seek care at or are 
referred to specialized hospitals probably dif-
fer from those in general hospitals. We 
totally agree. In a study in the southeastern 
part of The Netherlands, surgically treated 
pancreatic cancer patients who were referred 
to university hospitals were younger, more 
often male, more often diagnosed with stage 
3, exhibited less comorbidity, and had a 
higher socioeconomic status than patients 
surgically treated in general hospitals ( 2 ). 
Furthermore, in a previous study ( 3 ) with 
data on all patients diagnosed with 
International Federation of Gynecology and 
Obstetrics (FIGO) stage 2 or 3 ovarian can-
cer in the region of the population-based 
Eindhoven Cancer Registry, we found that 
age, FIGO stage, presence of comorbidity, 
and year of diagnosis were independent 
predictors of receiving the advised treatment 
(combination of surgery and chemotherapy). 
Furthermore, both age and the treatment 
with surgery and chemotherapy indepen-
dently affected overall survival, even after 
adjustment for comorbidity. Because the 
prognostic effect of age remained after adjust-
ment for comorbidity, age in itself or other 
factors related to increasing age must be 
responsible for the age effect. Performance 
status is one of the most important factors 
(independent of comorbidity), as Extermann 
et al. ( 4 ) have, indeed, found. Although 
comorbidity is routinely recorded from the 
medical records for all patients diagnosed 
with cancer in the Eindhoven Cancer Regis-
try ( 5 ), performance status could often not be 
extracted from the medical record. In an in-
depth retrospective study, we have attempted 
to register performance status for cancer 
patients, but this status remained unknown 
for approximately half of all patients. 
 We agree with Schrag that by working 
across international boundaries to develop 
consensus on data collection strategies, 
metrics, timing rules, and even systems for 
engaging patients in data collection more 
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directly, we can optimize the value of can-
cer registry data to provide information not 
only about cancer incidence and mortality 
but also about the optimal design of cancer 
care delivery. This goal is among those of 
Eurocourse project funded in the Seventh 
Framework Programme (FP7) of the 
European Union , which is starting soon. 
 In addition, feedback to the medical 
specialists about the importance of perfor-
mance status is also necessary. In the 
regional Dutch comprehensive cancer cen-
ters, we can accomplish this objective by 
giving feedback in the meetings of the 
regional tumor working groups, which are 
attended by medical specialists. 
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